New Drugs Approved To Treat TB; Access To Treatment Still Uncertain
Center for Global Health Policy’s “Science Speaks”: TB drug approvals, distribution deal inches options forward, but MDR-TB treatment access still uncertain where needed most
Antigone Barton, writer and editor of “Science Speaks” and senior communications officer at the Center for Global Health Policy, discusses recent TB drug approvals and potential challenges to accessing these drugs (5/12).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.